Dasatinib vs. imatinib in patients with chronic myeloid...

  • Main
  • 2020 / 4
  • Dasatinib vs. imatinib in patients with chronic myeloid...

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

Cortes, Jorge E., Jiang, Qian, Wang, Jianxiang, Weng, Jianyu, Zhu, Huanling, Liu, Xiaoli, Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald, Savona, Michael, Martin-Regueira, Patricia, Sy, Oumar, Gurn
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia
DOI:
10.1038/s41375-020-0805-1
Date:
April, 2020
File:
PDF, 1022 KB
2020
Conversion to is in progress
Conversion to is failed